$1.45 Billion is the total value of Vivo Capital, LLC's 54 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 9.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HRMY | Sell | Harmony Biosciences Holdings Inc | $222,338,000 | +6.8% | 4,570,148 | -6.4% | 15.31% | +21.9% |
| NFH | New Frontier Health Corp | $170,885,000 | +4.3% | 14,300,000 | 0.0% | 11.77% | +19.1% | |
| TIL | Instil Bio Inc | $134,233,000 | -37.2% | 12,486,787 | 0.0% | 9.24% | -28.2% | |
| ISEE | Buy | Iveric Bio Inc | $108,250,000 | +2.9% | 6,431,940 | +2.2% | 7.45% | +17.5% |
| SRRA | Buy | Sierra Oncology, Inc | $106,711,000 | +156.0% | 3,329,511 | +73.7% | 7.35% | +192.4% |
| ALXO | ALX Oncology Holdings Inc | $71,319,000 | -21.4% | 4,220,048 | 0.0% | 4.91% | -10.2% | |
| ASND | Ascendis Pharma A/Ssponsored adr | $51,932,000 | -12.8% | 442,502 | 0.0% | 3.58% | -0.4% | |
| AMRS | Amyris, Inc | $50,760,000 | -19.4% | 11,642,195 | 0.0% | 3.50% | -8.0% | |
| TARS | Tarsus Pharmaceuticals Inc | $50,247,000 | -25.2% | 2,987,331 | 0.0% | 3.46% | -14.6% | |
| SVA | Sinovac Biotech Ltd. | $38,173,000 | 0.0% | 5,900,000 | 0.0% | 2.63% | +14.2% | |
| Buy | Ventyx Biosciences Inc | $26,078,000 | -26.7% | 1,921,726 | +7.3% | 1.80% | -16.3% | |
| VRDN | Viridian Therapeutics Inc | $24,037,000 | -6.5% | 1,300,000 | 0.0% | 1.66% | +6.8% | |
| KALV | KalVista Pharmaceuticals Inc. | $22,605,000 | +11.4% | 1,533,559 | 0.0% | 1.56% | +27.3% | |
| CLDX | Buy | Celldex Therapeutics Inc | $21,402,000 | +14.3% | 628,356 | +29.7% | 1.47% | +30.6% |
| GERN | New | Geron Corp | $20,724,000 | – | 15,238,095 | +100.0% | 1.43% | – |
| AVDL | Avadel Pharmaceuticals PLCadr | $20,060,000 | -15.5% | 2,937,093 | 0.0% | 1.38% | -3.5% | |
| RLMD | Sell | Relmada Therapeutics Inc | $19,052,000 | -4.2% | 705,882 | -20.0% | 1.31% | +9.4% |
| IMPL | Impel NeuroPharma Inc | $18,376,000 | -26.2% | 2,884,789 | 0.0% | 1.26% | -15.7% | |
| GTH | Buy | Genetron Holdings Ltdads | $16,231,000 | -58.0% | 7,411,577 | +16.9% | 1.12% | -52.1% |
| IO Biotech Inc | $15,982,000 | -17.2% | 3,015,545 | 0.0% | 1.10% | -5.4% | ||
| VERA | New | Vera Therapeutics Inc | $15,660,000 | – | 666,666 | +100.0% | 1.08% | – |
| ACRS | Sell | Aclaris Therapeutics, Inc. | $15,492,000 | +15.7% | 898,631 | -2.4% | 1.07% | +32.2% |
| COGT | Cogent Biosciences Inc | $14,388,000 | -12.7% | 1,920,941 | 0.0% | 0.99% | -0.3% | |
| KDNY | Chinook Therapeutics Inc | $14,268,000 | +0.3% | 872,151 | 0.0% | 0.98% | +14.6% | |
| VRNA | Verona Pharma PLCads | $13,722,000 | -25.7% | 2,749,918 | 0.0% | 0.94% | -15.2% | |
| Sell | Aadi Bioscience Inc | $13,108,000 | -58.4% | 772,416 | -40.7% | 0.90% | -52.4% | |
| MRUS | Merus NV | $11,686,000 | -16.9% | 442,000 | 0.0% | 0.80% | -5.1% | |
| IOVA | Buy | Iovance Biotherapeutics Inc | $10,907,000 | +89.8% | 655,057 | +117.6% | 0.75% | +117.1% |
| BOLT | Bolt Therapeutics Inc | $10,607,000 | -44.1% | 3,871,291 | 0.0% | 0.73% | -36.2% | |
| Minerva Surgical Inc | $9,971,000 | -12.5% | 2,215,667 | 0.0% | 0.69% | 0.0% | ||
| LEGN | Legend Biotech Corp Sponsoredsponsored ads | $8,881,000 | -22.0% | 244,375 | 0.0% | 0.61% | -10.9% | |
| CDXS | Codexis, Inc | $8,004,000 | -34.1% | 388,144 | 0.0% | 0.55% | -24.7% | |
| ZLAB | Buy | Zai Lab Ltd ADRadr | $7,986,000 | -27.4% | 181,577 | +3.8% | 0.55% | -17.0% |
| TERN | Terns Pharmaceuticals Inc | $7,945,000 | -58.0% | 2,675,133 | 0.0% | 0.55% | -52.0% | |
| DSGN | Sell | Design Therapeutics | $7,697,000 | -32.3% | 476,589 | -10.2% | 0.53% | -22.7% |
| ALGS | Aligos Therapeutics Inc | $7,626,000 | -81.9% | 3,547,030 | 0.0% | 0.52% | -79.3% | |
| OLMA | Olema Pharmaceuticals Inc | $7,197,000 | -54.5% | 1,689,515 | 0.0% | 0.50% | -48.0% | |
| Sera Prognostics Inc | $7,034,000 | -44.8% | 1,856,011 | 0.0% | 0.48% | -37.1% | ||
| BLU | Bellus Health Inc | $6,998,000 | -14.5% | 1,017,152 | 0.0% | 0.48% | -2.4% | |
| ARWR | Arrowhead Pharmaceuticals Inc | $6,320,000 | -30.6% | 137,411 | 0.0% | 0.44% | -20.8% | |
| NKTX | Nkarta Inc | $5,829,000 | -25.9% | 512,225 | 0.0% | 0.40% | -15.4% | |
| DYN | Dyne Therapeutics Inc | $5,568,000 | -18.9% | 577,642 | 0.0% | 0.38% | -7.5% | |
| STSA | Satsuma Pharmaceuticals Inc | $4,683,000 | -15.6% | 1,232,394 | 0.0% | 0.32% | -3.6% | |
| MREO | Sell | Mereo Biopharma Group PLCads | $4,251,000 | -61.5% | 3,795,225 | -45.1% | 0.29% | -56.0% |
| Sell | Dice Therapeutics Inc | $3,121,000 | -62.2% | 163,136 | -50.0% | 0.22% | -56.8% | |
| CMPX | Compass Therapeutics Inc | $2,740,000 | -56.8% | 2,000,000 | 0.0% | 0.19% | -50.5% | |
| FIXX | Homology Medicines, Inc. | $2,594,000 | -16.5% | 853,143 | 0.0% | 0.18% | -4.3% | |
| ASLN | Aslan Pharmaceuticals Ltdads | $2,556,000 | -19.7% | 2,840,909 | 0.0% | 0.18% | -8.3% | |
| GRCL | Gracell Biotechnologies Incsponsored ads | $2,240,000 | -61.4% | 961,359 | 0.0% | 0.15% | -56.0% | |
| ZYME | Zymeworks Inc | $1,874,000 | -60.0% | 286,064 | 0.0% | 0.13% | -54.4% | |
| ELEV | Elevation Oncology Inc | $1,252,000 | -58.1% | 496,844 | 0.0% | 0.09% | -52.2% | |
| DTIL | Precision Biosciences Inc | $432,000 | -58.4% | 140,255 | 0.0% | 0.03% | -52.4% | |
| MTCR | Metacrine Inc | $89,000 | -10.1% | 146,426 | 0.0% | 0.01% | 0.0% | |
| EIGR | Eiger BioPharmaceuticals Inc | $35,000 | +59.1% | 4,166 | 0.0% | 0.00% | +100.0% | |
| ZGNX | Exit | Zogenix Inc | $0 | – | -105,000 | -100.0% | -0.10% | – |
| LRMR | Exit | Larimar Therapeutics Inc | $0 | – | -399,830 | -100.0% | -0.26% | – |
| EPIX | Exit | Essa Pharma Inc | $0 | – | -744,058 | -100.0% | -0.64% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
| CODEXIS INC | 29 | Q3 2023 | 8.0% |
| ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
| KALVISTA PHARMACEUTICALS INC | 25 | Q3 2023 | 3.9% |
| Verona Pharma PLC ADR | 24 | Q3 2023 | 7.6% |
| AMYRIS INC | 23 | Q3 2023 | 8.8% |
| EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
| Zai Lab Ltd ADR | 22 | Q3 2023 | 1.8% |
| Arrowhead Pharmaceuticals Inc | 21 | Q3 2023 | 6.9% |
| HOMOLOGY MEDICINES INC | 21 | Q3 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-22 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.